High-Dose Methotrexate in Osteosarcoma: Let the Questions Surcease—Time for Final Acceptance-Reference-Cited by-同舟云学术

High-Dose Methotrexate in Osteosarcoma: Let the Questions Surcease—Time for Final Acceptance

Published:2008-09-20 Issue:27 Volume:26 Page:4365-4366
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Jaffe Norman¹,Gorlick Richard²

Affiliation:

1. The University of Texas M. D. Anderson Cancer Center, Houston, TX

2. Children's Hospital at Montegiore, Bronx, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.14.7793

Reference18 articles.

1. Muggia FM, Louie AC: Five years of adjuvant chemotherapy: More questions than answers. Cancer Treat Rep 62:301,1978-305,

2. A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma.

3. Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't?

4. Jaffe N, Link M, Traggis D, et al: The role of high-dose methotrexate in osteogenic sarcoma in sarcomas in soft tissue and bone in childhood. Natl Cancer Inst Monogr 56:201,1981-206,

5. Goorin AM, Delorey M, Gelber RD, et al: The Dana Farber Cancer Institute/The Children's Hospital adjuvant chemotherapy trials for osteosarcoma: Three sequential studies. Cancer Treat Symp 3:155,1985-159,

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment;Biomedical Materials;2024-02-26

2. Different Subtypes of Osteosarcoma: Histopathological Patterns and Clinical Behaviour;Journal of Molecular Pathology;2023-05-16

3. Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines;Archives of Biochemistry and Biophysics;2023-01

4. Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high‑dose methotrexate based on individual pharmacokinetics: A retrospective study;Oncology Letters;2022-12-29

5. Injectable Tumor Microenvironment-Modulated Hydrogels with Enhanced Chemosensitivity and Osteogenesis for Tumor-Associated Bone Defects Closed-Loop Management;Chemical Engineering Journal;2022-12